Please note
This trial is no longer recruiting patients. We hope to add results when they are available.
Acute leukaemia, Blood cancers, Leukaemia
Closed
Phase 2
This study is looking at blinatumomab for people with acute myeloid leukaemia (AML). It is for people with AML that came back after induction chemotherapy and has a certain chromosome change.
Recruitment start: 5 September 2022
Recruitment end: 30 September 2024
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Richard Dillon
Amgen
Guy's and St Thomas' NHS Foundation Trust
Last reviewed: 29 Sept 2024
CRUK internal database number: 18183
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
